๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Inhaled tobramycin improves lung function in patients with cystic fibrosis,

โœ Scribed by Innes, Carmen

Book ID
120870460
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
2000
Weight
151 KB
Volume
&NA;
Category
Article
ISSN
1173-8324

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Reduced mortality in cystic fibrosis pat
Reduced mortality in cystic fibrosis patients treated with tobramycin inhalation solution
โœ Gregory S. Sawicki; James E. Signorovitch; Jie Zhang; Dominick Latremouille-Viau ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 110 KB

## Abstract ## Background Though tobramycin inhalation solution has been used for over a decade to improve lung function and reduce exacerbations in patients with cystic fibrosis (CF), its effects on mortality have not been wellโ€described. This study aimed to assess the association between use of

Falsely elevated serum tobramycin concen
Falsely elevated serum tobramycin concentrations in cystic fibrosis patients treated with concurrent intravenous and inhaled tobramycin
โœ Okan Elidemir; Stephanie R. Maciejewski; Christopher M. Oermann ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 24 KB ๐Ÿ‘ 1 views

A recently developed tobramycin preparation for inhalation (TOBIเฎพ, Pathogenesis Corp., Seattle, WA) is widely used in CF patients. It is often used in conjunction with intravenous tobramycin. Renal and ototoxicity associated with the use of tobramycin require that serum drug concentrations be monito